[Therapeutic results in osteoarticular tuberculosis; critical studies on the use of coli-vaccine, conteben, PAS, streptomycin and neoteben in 410 patients, with special reference to the limits of chemotherapy].
D010129:4-Aminobenzoic Acid / Q000627:therapeutic use*; D009525:Niacin; D009539:Nicotinic Acids / Q000627:therapeutic use*; D013307:Streptomycin / Q000627:therapeutic use*; D013828:Thioacetazone; D013882:Thiosemicarbazones / Q000627:therapeutic use*; D014376:Tuberculosis; D014394:Tuberculosis, Osteoarticular / Q000628:therapy*; D014611:Vaccination / Q000627:therapeutic use*; D014612:Vaccines / Q000627:therapeutic use*
D009539:Nicotinic Acids; D013882:Thiosemicarbazones; D014612:Vaccines; D009525:Niacin; D013828:Thioacetazone; D010129:4-Aminobenzoic Acid; D013307:Streptomycin
NICOTINIC ACID ISOMERS/therapeutic use; PARA-AMINOBENZOIC ACID/therapeutic use; STREPTOMYCIN/therapeutic use; THIOSEMICARBAZONES/therapeutic use; TUBERCULOSIS, OSTEOARTICULAR/therapy; VACCINES AND VACCINATION/therapeutic use
Behandlungsergebnisse der Knochen- und Gelenktuberkulose; Kritische Untersuchung der Beeinflussung mittels Koli-Vakzine, Conteben, PAS, Streptomycin und Neoteben bei 410 Patienten unter besonderer Berücksichtigung der Grenzen der Chemotherapie.